Literature DB >> 6100150

Model for cachexia in chronic disease: secretory products of endotoxin-stimulated macrophages induce a catabolic state in 3T3-L1 adipocytes.

P H Pekala, S R Price, C A Horn, B E Hom, J Moss, A Cerami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6100150

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN： 0066-9458


× No keyword cloud information.
  8 in total

Review 1.  A decade of progress in adipose tissue macrophage biology.

Authors:  Andrea A Hill; W Reid Bolus; Alyssa H Hasty
Journal:  Immunol Rev       Date:  2014-11       Impact factor: 12.988

Review 2.  Cytokines and proteoglycans.

Authors:  J J Nietfeld
Journal:  Experientia       Date:  1993-05-15

Review 3.  Cachexia in malaria and heart failure: therapeutic considerations in clinical practice.

Authors:  M E Onwuamaegbu; M Henein; A J Coats
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401

4.  Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.

Authors:  K R Feingold; C Grunfeld
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

5.  Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue.

Authors:  I C Kettelhut; A L Goldberg
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

6.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.

Authors:  P A Kern; M Saghizadeh; J M Ong; R J Bosch; R Deem; R B Simsolo
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 7.  Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.

Authors:  B Sherry; A Cerami
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

8.  Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).

Authors:  S Dessì; B Batetta; O Spano; G J Bagby; L Tessitore; P Costelli; F M Baccino; P Pani; J M Argilès
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.